Evidence map›Paper›PMID 10207103›Full record

ArticleMolecular and cellular biology1999

hSiah2 is a new Vav binding protein which inhibits Vav-mediated signaling pathways.

A Germani, F Romero, M Houlard, J Camonis, S Gisselbrecht, S Fischer, N Varin-Blank

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. The ubiquitin ligase Siah2 and the hypoxia response.Molecular cancer research : MCR · 2009
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Generation and analysis of Siah2 mutant mice.Molecular and cellular biology · 2003
    Article
  11. A binding motif for Siah ubiquitin ligase.Proceedings of the National Academy of Sciences of the United States of America · 2003
    Article
  12. Article
  13. Article
  14. Vav1 is a component of transcriptionally active complexes.The Journal of experimental medicine · 2002
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Regulatory and signaling properties of the Vav family.Molecular and cellular biology · 2000
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

A GermaniInstitut Cochin de Génétique Moléculaire, U363 INSERM, Hôpital Cochin, Université Paris V, 75014 Paris, France. germani@cochin.inserm.fr
F Romero
M Houlard
J Camonis
S Gisselbrecht
S Fischer
N Varin-Blank
Hôpital Cochin · FRUniversité Paris Cité · FRInstitut Cochin · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hematopoietic proto-oncogene vav has been characterized as a Rac1-GDP/GTP exchanger protein which regulates cytoskeletal reorganization as well as signaling pathways leading to the activation of stress-activated protein kinases (SAPK/JNKs). Furthermore, vav overexpression enhances basal and T-cell receptor (TCR)-mediated stimulation of the nuclear factor of activated T cells (NFAT). We report here the interaction between Vav and hSiah2, a mammalian homolog of Drosophila Seven in absentia (Sina) that has been implicated in R7 photoreceptor cell formation during Drosophila eye development via the proteasome degradation pathway. Vav and hSiah2 interact in vitro and in vivo and colocalize in the cytoplasm of hematopoietic cells. The Src homology domain of Vav and the C-terminal region of hSiah2 are required for this interaction. We provide evidence for a negative regulation by hSiah2 of Vav-induced basal and TCR-mediated NFAT-dependent transcription. Overexpression of hSiah2 also inhibits the onco-Vav-induced JNK activation. Although the Vav-interacting domain is located in the C-terminal portion of hSiah2, the N-terminal region of hSiah2 is necessary for the inhibitory role that seems to be independent of the proteasome degradation.

Indexed as

Mitogen-Activated Protein KinasesAnimalsCalcium-Calmodulin-Dependent Protein KinasesCOS CellsDNA-Binding ProteinsEnzyme ActivationFluorescent Antibody TechniqueGenes, ReporterHumansJNK Mitogen-Activated Protein KinasesJurkat CellsNFATC Transcription FactorsNuclear ProteinsOncogene ProteinsProto-Oncogene MasProto-Oncogene Proteins c-vavCalcium-Calmodulin-Dependent Protein KinasesDNA-Binding ProteinsJNK Mitogen-Activated Protein KinasesMAS1 protein, humanMitogen-Activated Protein KinasesNFATC Transcription FactorsNuclear ProteinsOncogene ProteinsProto-Oncogene MasProto-Oncogene Proteins c-vavReceptors, Antigen, T-CellSeven in Absentia ProteinsTranscription FactorsUbiquitin-Protein LigasesVAV1 protein, human

Identifiers

PMID10207103
PMCPMC84217
OpenAlexW2126749556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.